LD-2 disclosure · 4th Quarter - Report
AMARIN PHARMA, INC.
Income$80Kfee reported
Client
- Name
- AMARIN PHARMA, INC.
- Description
- Manufacturing
- Location
- New Jersey · United States of America
Registrant
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Advocacy related to cardiovascular health and reduction of residual risk after statins; National Defense Authorization Act for Fiscal Year 2021 (S.4049/H.R.6395)
LobbyistsALLISON F KASSIR · SCOTT DZIENGELSKI · mr DAVID JOSEPH FARBER
Covered position (SCOTT DZIENGELSKI): Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)